Net Income (Loss) Attributable to Parent in USD of HTG MOLECULAR DIAGNOSTICS, INC from Q1 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2014 to Q1 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Net Income (Loss) Attributable to Parent for the quarter ending 31 Mar 2023 was -$5,054,772.000, a 22.2% increase year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC Net Income (Loss) Attributable to Parent for the twelve months ending 31 Mar 2023 was -$20,151,729.000, a 7.22% decline year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Net Income (Loss) Attributable to Parent for 2022 was -$21,594,476.000, a 26% decline from 2021.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Net Income (Loss) Attributable to Parent for 2021 was -$17,145,170.000, a 17.8% increase from 2020.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Net Income (Loss) Attributable to Parent for 2020 was -$20,870,218.000, a 8.15% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$20,151,729 -$5,054,772 +$1,442,747 +22.2% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 -$21,594,476 -$4,692,600 +$498,689 +9.6% 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023
Q3 2022 -$22,093,165 -$4,516,148 -$25,526 -0.57% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 -$22,067,639 -$5,888,209 -$3,273,257 -1.3% 01 Apr 2022 30 Jun 2022 10-Q 10 Nov 2022
Q1 2022 -$18,794,382 -$6,497,519 -$1,649,212 -34% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$17,145,170 -$5,191,289 -$901,308 -21% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$16,243,862 -$4,490,622 +$921,166 +17% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$17,165,028 -$2,614,952 +$3,095,599 +54.2% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$20,260,627 -$4,848,307 +$609,591 +11.2% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$20,870,218 -$4,289,981 +$99,335 +2.3% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 -$20,969,553 -$5,411,788 -$671,556 -14.2% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$20,297,997 -$5,710,551 -$913,281 -19% 01 Apr 2020 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 -$19,384,716 -$5,457,898 -$87,052 -1.6% 01 Jan 2020 31 Mar 2020 10-Q 10 Nov 2021
Q4 2019 -$19,297,664 -$4,389,316 -$2,261,482 -1.1% 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021
Q3 2019 -$17,036,182 -$4,740,232 +$103,176 +2.1% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$17,139,358 -$4,797,270 -$694,541 -16.9% 01 Apr 2019 30 Jun 2019 10-Q 10 Nov 2020
Q1 2019 -$16,444,817 -$5,370,846 +$9,101 +0.17% 01 Jan 2019 31 Mar 2019 10-Q 10 Nov 2020
Q4 2018 -$16,453,918 -$2,127,834 -$205,839 -10.7% 01 Oct 2018 31 Dec 2018 10-K 25 Mar 2020
Q3 2018 -$16,248,079 -$4,843,408 +$537,438 +10% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$16,785,517 -$4,102,729 +$1,738,173 +29.8% 01 Apr 2018 30 Jun 2018 10-Q 12 Nov 2019
Q1 2018 -$18,523,690 -$5,379,947 +$436,327 +7.5% 01 Jan 2018 31 Mar 2018 10-Q 12 Nov 2019
Q4 2017 -$18,960,017 -$1,921,995 +$3,751,086 +66.1% 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 -$22,711,103 -$5,380,846 +$1,107,596 +17.1% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$23,818,699 -$5,840,902 +$1,010,701 +14.8% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$24,829,400 -$5,816,274 +$1,210,150 +17.2% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 -$26,039,550 -$5,673,081 +$26,571 +0.47% 01 Oct 2016 31 Dec 2016 10-K 23 Mar 2018
Q3 2016 -$26,066,121 -$6,488,442 -$1,330,779 -25.8% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 -$24,735,342 -$6,851,603 -$399,261 -6.2% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017
Q1 2016 -$24,336,081 -$7,026,424 -$2,938,290 -71.9% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$21,397,791 -$5,699,652 -$1,560,987 -37.7% 01 Oct 2015 31 Dec 2015 10-K 23 Mar 2017
Q3 2015 -$19,836,804 -$5,157,663 -$1,850,334 -55.9% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$17,986,470 -$6,452,342 -$2,767,516 -75.1% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 -$15,218,954 -$4,088,134 -$1,260,546 -44.6% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016
Q4 2014 -$13,958,408 -$4,138,665 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016
Q3 2014 -$3,307,329 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015
Q2 2014 -$3,684,826 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 -$2,827,588 01 Jan 2014 31 Mar 2014 10-Q 08 Jun 2015

HTG MOLECULAR DIAGNOSTICS, INC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$21,594,476 -$4,449,306 -26% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 -$17,145,170 +$3,725,048 +17.8% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$20,870,218 -$1,572,554 -8.1% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 -$19,297,664 -$2,843,746 -17.3% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021
2018 -$16,453,918 +$2,506,099 +13.2% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2020
2017 -$18,960,017 +$7,079,533 +27.2% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019
2016 -$26,039,550 -$4,641,759 -21.7% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018
2015 -$21,397,791 -$7,439,383 -53.3% 01 Jan 2015 31 Dec 2015 10-K 23 Mar 2017
2014 -$13,958,408 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.